A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.-论文-万方医学网

第一作者： Fatemeh,Seyednasrollah

第一单位： Fatemeh Seyednasrollah and Laura L. Elo, Turku Centre for Biotechnology; University of Turku; Åbo Akademi University, Turku, Finland; Devin C. Koestler, University of Kansas Medical Center, Kansas City, KS; Tao Wang, University of Texas Southwestern Medical Center, Dallas, TX; Stephen R. Piccolo, Brigham Young University, Provo; University of Utah, Salt Lake City, Utah, UT; Roberto Vega, Russell Greiner, and Luke Kumar, University of Alberta; Alberta Innovates Centre for Machine Learning, Edmonton, Alberta, Canada; Christiane Fuchs, Helmholtz Zentrum München, Neuherberg; Technische Universität München, Garching, Germany; Eyal Gofer, The Hebrew University, Jerusalem, Israel; Russell D. Wolfinger, SAS Institute, Cary, NC; Kimberly Kanigel Winner and James C. Costello, University of Colorado, Anschutz Medical Campus, Aurora, CO; Chris Bare, Elias Chaibub Neto, Thomas Yu, Thea Norman, and Justin Guinney, Sage Bionetworks, Seattle, WA; Liji Shen and Fang Liz Zhou, Sanofi, Bridgewater, NJ; Kald Abdallah, AstraZeneca, Gaithersburg, MD; Gustavo Stolovitzky, IBM Research, Yorktown Heights; Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Howard R. Soule, Prostate Cancer Foundation, Santa Monica; Charles J. Ryan, University of California, San Francisco, CA; Christopher J. Sweeney, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Oliver Sartor, Tulane University, New Orleans, LA.

作者： Fatemeh,Seyednasrollah ^[1] ; Devin C,Koestler ^[1] ; Tao,Wang ^[1] ; Stephen R,Piccolo ^[1] ; Roberto,Vega ^[1] ; Russell,Greiner ^[1] ; Christiane,Fuchs ^[1] ; Eyal,Gofer ^[1] ; Luke,Kumar ^[1] ; Russell D,Wolfinger ^[1] ; Kimberly,Kanigel Winner ^[1] ; Chris,Bare ^[1] ; Elias Chaibub,Neto ^[1] ; Thomas,Yu ^[1] ; Liji,Shen ^[1] ; Kald,Abdallah ^[1] ; Thea,Norman ^[1] ; Gustavo,Stolovitzky ^[1] ; Howard R,Soule ^[1] ; Christopher J,Sweeney ^[1] ; Charles J,Ryan ^[1] ; Howard I,Scher ^[1] ; Oliver,Sartor ^[1] ; Laura L,Elo ^[1] ; Fang Liz,Zhou ^[1] ; Justin,Guinney ^[1] ; James C,Costello ^[1] ; Prostate Cancer DREAM Challenge Community

作者单位： Fatemeh Seyednasrollah and Laura L. Elo, Turku Centre for Biotechnology; University of Turku; Åbo Akademi University, Turku, Finland; Devin C. Koestler, University of Kansas Medical Center, Kansas City, KS; Tao Wang, University of Texas Southwestern Medical Center, Dallas, TX; Stephen R. Piccolo, Brigham Young University, Provo; University of Utah, Salt Lake City, Utah, UT; Roberto Vega, Russell Greiner, and Luke Kumar, University of Alberta; Alberta Innovates Centre for Machine Learning, Edmonton, Alberta, Canada; Christiane Fuchs, Helmholtz Zentrum München, Neuherberg; Technische Universität München, Garching, Germany; Eyal Gofer, The Hebrew University, Jerusalem, Israel; Russell D. Wolfinger, SAS Institute, Cary, NC; Kimberly Kanigel Winner and James C. Costello, University of Colorado, Anschutz Medical Campus, Aurora, CO; Chris Bare, Elias Chaibub Neto, Thomas Yu, Thea Norman, and Justin Guinney, Sage Bionetworks, Seattle, WA; Liji Shen and Fang Liz Zhou, Sanofi, Bridgewater, NJ; Kald Abdallah, AstraZeneca, Gaithersburg, MD; Gustavo Stolovitzky, IBM Research, Yorktown Heights; Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Howard R. Soule, Prostate Cancer Foundation, Santa Monica; Charles J. Ryan, University of California, San Francisco, CA; Christopher J. Sweeney, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Oliver Sartor, Tulane University, New Orleans, LA. ^[1]

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验(主题)(Clinical Trials as Topic);人类(Humans);男(雄)性(Male);Meta分析(主题)(Meta-Analysis as Topic);中年人(Middle Aged);模型, 理论(Models, Theoretical);泼尼松(Prednisone);预后(Prognosis);时间因素(Time Factors);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1200/CCI.17.00018

PMID 30657384

发布时间 2019-12-07

检索历史清除

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.

JCO clinical cancer informatics

相似文献

JCO clinical cancer informatics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.

JCO clinical cancer informatics

相似文献

JCO clinical cancer informatics

相关期刊

检索历史清除